2m 2m 2m 2m 2m 2m 2m
ORUKA THERA (ORKA)
NASDAQ
$95.76-$0.56 (-0.58%)
Price as of Nov 18, 2026 3:54 PM EST- $6.5BMarket Cap
- 250.89%1-Year Change
- BiotechnologyIndustry
ORUKA THERA (ORKA)
$95.76-$0.56 (-0.58%)
ORKA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $96.32 | ||
Change | -$2.92 (-2.94%) | ||
Open | $98.51 | ||
High | $100.77 | ||
Low | $95.05 | ||
Previous Close | $99.24 | ||
Volume | 780,186 | ||
30-Day Average Volume | 987,732 | ||
1-Week Change | -12.04% | ||
1-Month Change | 33.91% | ||
1-Year Change | 250.89% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 67.8M | ||
Total Assets | $1.2B | ||
Market Cap | $6.5B | ||
Enterprise Value | $6.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$53.3M | ||
Free Cash Flow | -$44.4M | ||
EBIT | -$53.3M | ||
EBITDA | -$53.3M | ||
Net Working Capital | $909.7M | ||
EPS | -$0.63 | ||
Enterprise Value/EBITDA | -119 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -153 | ||
PEG | 11 | ||
Price/Free Cash Flow | -147 | ||
Price/Operating Cash Flow | -147 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue